Mallinckrodt appoints Frank B. Raciti as Controller and Chief Accounting Officer

Keenova Therapeutics plc

Frank B. Raciti appointed Controller & CAO effective August 19, 2025.
Raciti previously served as SVP, Controller & CAO at Endo since March 2025; joined Mallinckrodt after its Endo merger on July 31, 2025.
CFO Bryan M. Reasons ceases to serve as principal accounting officer upon Raciti's appointment.
Raciti is a CPA (Pennsylvania) and spent 14 years at PricewaterhouseCoopers including SEC Services.
Raciti entered into a customary indemnification arrangement with the company.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.